Tuesday, May 5, 2015

Wednesday, May 6, 2015

SESSION 1: Back to Biotech - Personalised Medicine and New Drug Development

SESSION 2: Workshops

  • Sponsor: Aptar Pharma
    Moderator: Gerallt Williams, Ph.D. 

    2:00 p.m. - 6:00 p.m.

    The following companies each sponsored 60-minute interactive presentations on new technologies and services. Participants could select and attend THREE of these sessions.

    3M Drug Delivery Systems 
    Evolving Regulatory Requirements for pMDI Registrations in the US

    AstraZeneca 
    Prediciting the Fate of Inhaled Molecules and Applying this Knowledge during Development

    FluidDA
    Demonstrating the Value of Regional Imaging Biomarkers in Respiratory Drug Development through Functional Respiratory Imaging (FRI)

    Gateway Analytical
    Assessing Aggregate Performance and the Presence of Foreign Particulate in OINDP's

    Harro Höfliger Verpackungsmaschinen
    The Challenge of Filling Dry Powder Inhalers including Injection Molded Disks

    Hovione
    Integrating DPI Development from Inhaler Design to Particle Engineering and Formulation Strategy

    International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS)
    Abbreviated Impactor Measurement (AIM) and Effective Data Analysis (EDA) of Aerodynamic Particle Size Data from Orally Inhaled Products (OIP): How to Link with the Product Lifecycle

    Nypro Healthcare
    Integrating Predictive Design Tools to Achieve a Robust Inhalation Device Design

    Proveris Scientific
    Application of New Testing Technologies and Methods to Determine Critical Quality Attributes of pMDIs

    Qualicaps
    Inhaler Device Selection, Comparison of Capsule-based pMDIs and Mulit-dose DPIs

    rap.ID  Particle Systems
    Chemical Identification of Micro Particles from 2 µm and Up: Technology, Application and Validation

    Toxikon Europe
    Using Leachable Studies to Assist in Establishing an "Organic Impurity Profile" for Inhalation Drug Products

Thursday, May 7, 2015

SESSION 3: Posters on the Podium

SESSION 4: Global Patent Practice

SESSION 5: Targeting Nasal Drug Delivery

SESSION 6: Building on Pulmonary and Nasal Delivery: Exploring Alternative Technologies

Friday, May 8, 2015

SESSION 7: Particle Engineering and QbD

SESSION 8: Are there Alternative Distribution Practices for Inhalers?

↑ Back to Top